Evidence map›Paper›PMID 40665035›Full record

ReviewUrologie (Heidelberg, Germany)2025

[Integration of complementary medicine in uro-oncology].

Carolin C Hack, Katharina Seitz, Imke Thederan, Pia Wüfling, Bernd Wullich, Laura Bellut, Hans Joachim Herrmann, Yurdagül Zopf

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Urologie (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Carolin C HackFrauenklinik, Comprehensive Cancer Center Erlangen-EMN, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Deutschland. carolin.hack@uk-erlangen.de.
Katharina SeitzFrauenklinik, Comprehensive Cancer Center Erlangen-EMN, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Deutschland.
Imke ThederanMartini-Klinik am UKE GmbH, Hamburg, Deutschland.
Pia WüflingPINK gegen Brustkrebs GmbH, Hamburg, Deutschland.
Bernd WullichKlinik für Urologie und Kinderurologie, Universitätsklinikum Erlangen, Erlangen, Deutschland.
Laura BellutKlinik für Urologie und Kinderurologie, Universitätsklinikum Erlangen, Erlangen, Deutschland.
Hans Joachim HerrmannHector Center für Ernährung, Bewegung und Sport, Comprehensive Cancer Center Erlangen-EMN, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Deutschland.
Yurdagül ZopfHector Center für Ernährung, Bewegung und Sport, Comprehensive Cancer Center Erlangen-EMN, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of complementary medicine is growing in all fields of oncology.

objectivesThis article aims to highlight the importance of integrating complementary medicine into uro-oncology.

methodsBased on current literature, an overview of the current state of complementary medicine and its importance in treatment management in uro-oncology is provided, as well as future opportunities and challenges.

resultsComplementary medicine offers a valuable complement to conventional medicine in uro-oncology. While there is very good evidence for some procedures, which is reflected in the S3 guideline on complementary medicine for oncology patients, scientific evidence is lacking for others. Classic natural healing modalities, such as phytotherapy, hydrotherapy, nutrition, and exercise, can help improve patients' physical and psychological well-being, reduce complications and side effects, and achieve treatment goals.

conclusionIn recent years, complementary medicine has become established in oncology. It offers the opportunity to improve quality of life and treatment management, including in uro-oncology. It will continue to gain importance in the coming years.

Indexed as

Complementary TherapiesIntegrative OncologyUrologic NeoplasmsHumansIntegrative MedicineMedical OncologyUrologyCancerIntegrative medicineNaturopathic medicineQuality of lifeTreatment management

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.